WHO/Mukhsindzhon Abidzhanov
© Credits

Supporting vaccine-preventable disease elimination and eradication efforts

Measles and rubella elimination

The Member States of the European Region recommitted to the joint goal of eliminating measles and rubella, through unanimous adoption of the European Vaccine Action Plan 2015-2020 (EVAP). WHO/Europe supports Member States in their efforts to reach this milestone.

A Regional Verification Commission for Measles and Rubella elimination (RVC) was established in 2011, for which WHO/Europe serves as secretariat. This independent group of experts is tasked with verifying measles and rubella elimination in the WHO European Region. National verification committees for measles and rubella elimination (NVCs) compile and submit data annually to the RVC, in order to provide evidence for the interruption of measles and rubella transmission per country and eventually for the Region as a whole.

Polio eradication

At an historic ceremony held in Copenhagen in 2002, the European Regional Commission for the Certification of Poliomyelitis Eradication (RCC) certified that indigenous transmission of wild poliovirus (polio) in the European Region had ceased. Certification followed years of intensive effort by Member States, supported by a public–private coalition of WHO, the United Nations Children’s Fund (UNICEF), Rotary International and the United States Centers for Disease Control and Prevention (CDC). This collective achievement demonstrated the value of large, internationally coordinated vaccination campaigns and of special efforts to reach traditionally underserved groups, such as migrants or nomads.

By 2010, however, immunity had dropped to the point where an importation of wild polio type 1 led to a large polio outbreak in Tajikistan and three neighbouring countries. This outbreak led to 478 cases in both adults and children, and it killed 29.

As of the start of 2017, circulation of wild polio was at its lowest levels since records began, with fewer cases in fewer districts of fewer countries than at any previous time. Polio remains endemic in parts of only three countries. Until polio is eradicated worldwide, however, all polio-free regions, including the European Region, remain at risk of importation. WHO/Europe supports Member States in their efforts to maintain the Region’s polio-free status.

News

All →

Publications

All →
Communicating about vaccination with caregivers and patients: facilitator guide

This facilitator guide accompanies the training module, Communicating about vaccination with caregivers and patients. The facilitator guide provides instructions,...

Report of the Twenty-fourth Meeting of the European Technical Advisory Group of Experts on Immunization (‎ETAGE)‎, Copenhagen, Denmark, 5–6 November 2024

At its twenty-fourth meeting, held on 5–6 November 2024, the European Technical Advisory Group of Experts on Immunization (‎ETAGE)‎ reviewed...

Related activities

All →
Advancing immunization equity

Advancing immunization equity

WHO
© Credits

Overview

WHO works with countries to resolve immunization inequities by embedding equity into the heart of immunization programmes. Immunization inequities are avoidable differences in immunization coverage between individuals and groups within a population.

Simply making vaccines available to everyone is not sufficient to achieve equitable uptake; tailored services may be needed to reach some communities or individuals, often including those at higher risk of infections and severe outcomes. Despite overall high coverage at the level of the WHO European Region, over 500 000 children in the Region still miss one or more recommended vaccinations each year.

Embedding equity into immunization programmes means developing processes to continuously:

  • identify who has not been vaccinated according to the national routine immunization schedule;
  • understand why they were left behind by identifying the barriers they face in accessing immunization programmes;
  • decide how to intervene to resolve or avoid this; and
  • determine if these interventions make a difference (and are sustainable).

This requires that all levels of the immunization programme understand the importance of equity and take action – from immunizers and other health-care providers on the ground to those developing policy at the national level. Addressing immunization inequities may also involve adapting policy and procedures at national, regional or local levels and allocating additional resources to support interventions.

WHO supports its Member States in all phases of strengthening equity in immunization, including:

  • detecting and tracking inequities through surveillance;
  • conducting research to understand the reasons individuals and populations are under-vaccinated;
  • developing and monitoring the effectiveness of tailored, multi-component interventions to resolve immunization inequities; and
  • providing recommendations and guidelines, such as a practical guide to identifying, addressing and tracking inequities in immunization.

Related health topics